Pitching session Call 7, topic 3 - Clinical validation of biomarkers (1/2)

Поделиться
HTML-код
  • Опубликовано: 21 ноя 2024
  • List of participants delivering a pitch:
    Chapters
    00:00 Introduction
    0:50 Emma BRODRICK
    Existing
    Rapid Biomarker Analysis at POC
    6:50 Luiz CORREA
    Diagnostic Data Hub
    Digital Transformation of Patient Consent (DigiConsent): Enhancing Efficiency in Healthcare Through E-Consent
    12:30 Caroline DESVERGNE
    CEA Leti
    Point-of-care devices and robust wearables to improve the clinical use of biomarkers (cellular, molecular, physiological)
    17:05 Francesco FASCETTI-LEON
    Pediatric Surgery Unit, Women's and childrens' health Department, Padova University
    Non-invasivE multimodal monitoring tools for NeCrotizing enterocolitis in preterm infants: A piLot MulticEnteR sTudy (NEC-ALERT)
    21:13 Kevser FÜNFGELD
    Luxembourg Institute of Health
    Development and implementation of virtual patient avatars derived from standardised, minimally and non-invasive biomarkers for enhanced clinical trials
    25:47 Alexandra GEORGESCU
    Thymia
    Validation of multimodal biomarkers of mental health
    30:10 Juan Ignacio IMBAUD
    PROTEIN ALTERNATIVES SL
    SEC6 signature: genomic biomarkers for recurrence prediction and treatment guidance in early-stage Colorectal Cancer patients
    35:06 Georgi KADREV
    Kelvin Health
    Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response
    40:27 Elma KERZ
    Exaia Technologies
    Trustworthy & Explainable AI for Mental Health Assessment: Harnessing NLP and ML/DL for the Detection, Timely Treatment and Remote Monitoring of Neurodegenerative and Psychiatric Disorders
    45:16 Nicola KIELLAND
    IDIAP Jordi Gol
    Primary Care, a real-world environment
    50:10 Irakli LEZHAVA
    Ensofy
    Vocal Biomarkers for Mental Health Management
    54:13 Shima MAHMOUDI
    Silesian University of Technology
    Advancing Tuberculosis Research: Unraveling Biomarkers for Enhanced Diagnostics, Prognostics, and Treatment Monitoring
    59:04 Monika MATUSIAK
    Institute of Physiology and Pathology of Hear
    Molecular biomarkers of neuroplasticity after congenital deafness treatment by cochlear implantation - is serum level of MMP-9 a one?
    1:03:18 Margaret MC GEE
    University College Dublin
    Clinical translation of Extracellular Vesicles as liquid biopsy for disease detection and monitoring
    1:07:44 Avidan NEUMANN
    Institute of Environmental Medicine @ Helmholtz Munich
    Biomarker for early prediction of COVID-19 disease progression
    1:11:48 Johannes ÖSTERBERG
    Sooma Medical
    Biomarkers for novel depression treatment
    1:16:02 Anouk POST
    VU University
    Advanced endoscopic imaging to visualize fluorescently-labelled molecules in vivo
    1:20:03 Lauri RANNASTE
    VTT Technical Research Centre of Finland Ltd
    Development and production of diagnostic devices for point-of-care testing
    1:24:16 Christoph SACHSENMAIER
    Epimune Diagnostics
    Clinical Validation of Epigenetic Immune Cell Quantification for Early Diagnosis and Management of Patients with Disorders of the Immune System
    1:28:38 Ines VALLEDOR
    Certest Biotec
    Certest's NGS Comprehensive Adaptive Platform to Address Unmet Medical Needs

Комментарии •